If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...
Needham & Company LLC reissued their hold rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research note released on Wednesday morning,Benzinga reports. Several other research ...
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ...
WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMD ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results